AUPN443995A0 - Papillomavirus polyprotein - Google Patents

Papillomavirus polyprotein

Info

Publication number
AUPN443995A0
AUPN443995A0 AUPN4439A AUPN443995A AUPN443995A0 AU PN443995 A0 AUPN443995 A0 AU PN443995A0 AU PN4439 A AUPN4439 A AU PN4439A AU PN443995 A AUPN443995 A AU PN443995A AU PN443995 A0 AUPN443995 A0 AU PN443995A0
Authority
AU
Australia
Prior art keywords
polyprotein
papillomavirus
papillomavirus polyprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN4439A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
CSL Ltd
Original Assignee
University of Queensland UQ
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland UQ, CSL Ltd filed Critical University of Queensland UQ
Priority to AUPN4439A priority Critical patent/AUPN443995A0/en
Publication of AUPN443995A0 publication Critical patent/AUPN443995A0/en
Priority to ZA966381A priority patent/ZA966381B/xx
Priority to CA2228221A priority patent/CA2228221C/en
Priority to PCT/AU1996/000473 priority patent/WO1997005164A1/en
Priority to EP96924715A priority patent/EP0840747A4/en
Priority to AU65102/96A priority patent/AU699547B2/en
Priority to NZ313108A priority patent/NZ313108A/xx
Priority to JP9507011A priority patent/JPH11510688A/ja
Priority to EP07075286A priority patent/EP1847549A3/en
Priority to US09/000,094 priority patent/US6365160B1/en
Priority to NZ334582A priority patent/NZ334582A/xx
Priority to US10/011,749 priority patent/US6726912B1/en
Priority to JP2006285406A priority patent/JP2007054074A/ja
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AUPN4439A 1995-07-27 1995-07-27 Papillomavirus polyprotein Abandoned AUPN443995A0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
AUPN4439A AUPN443995A0 (en) 1995-07-27 1995-07-27 Papillomavirus polyprotein
NZ334582A NZ334582A (en) 1995-07-27 1996-07-26 Polyprotein construct of a papillomavirus
NZ313108A NZ313108A (en) 1995-07-27 1996-07-26 Papillomavirus polyprotein constructs
CA2228221A CA2228221C (en) 1995-07-27 1996-07-26 Papillomavirus polyprotein constructs
PCT/AU1996/000473 WO1997005164A1 (en) 1995-07-27 1996-07-26 Papillomavirus polyprotein constructs
EP96924715A EP0840747A4 (en) 1995-07-27 1996-07-26 PAPILLOMAVIRUS POLYPROTEIN RECOMBINATION PRODUCTS
AU65102/96A AU699547B2 (en) 1995-07-27 1996-07-26 Papillomavirus polyprotein constructs
ZA966381A ZA966381B (en) 1995-07-27 1996-07-26 Papillomavirus polyprotein constructs
JP9507011A JPH11510688A (ja) 1995-07-27 1996-07-26 パピローマウイルスのポリプロテイン構築物
EP07075286A EP1847549A3 (en) 1995-07-27 1996-07-26 Papillomavirus polyprotein constructs
US09/000,094 US6365160B1 (en) 1995-07-27 1996-07-26 Papillomavirus polyprotein constructs
US10/011,749 US6726912B1 (en) 1995-07-27 2001-12-11 Papillomavirus polyprotein constructs
JP2006285406A JP2007054074A (ja) 1995-07-27 2006-10-19 パピローマウイルスのポリプロテイン構築物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN4439A AUPN443995A0 (en) 1995-07-27 1995-07-27 Papillomavirus polyprotein

Publications (1)

Publication Number Publication Date
AUPN443995A0 true AUPN443995A0 (en) 1995-08-17

Family

ID=3788774

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN4439A Abandoned AUPN443995A0 (en) 1995-07-27 1995-07-27 Papillomavirus polyprotein

Country Status (8)

Country Link
US (2) US6365160B1 (cg-RX-API-DMAC7.html)
EP (2) EP1847549A3 (cg-RX-API-DMAC7.html)
JP (2) JPH11510688A (cg-RX-API-DMAC7.html)
AU (1) AUPN443995A0 (cg-RX-API-DMAC7.html)
CA (1) CA2228221C (cg-RX-API-DMAC7.html)
NZ (1) NZ313108A (cg-RX-API-DMAC7.html)
WO (1) WO1997005164A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA966381B (cg-RX-API-DMAC7.html)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
US7611713B2 (en) * 1993-03-05 2009-11-03 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide compositions
AUPN015794A0 (en) * 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
US6509149B2 (en) * 1995-06-06 2003-01-21 Hybridon, Inc. HPV-specific oligonucleotides
US6030771A (en) * 1997-08-25 2000-02-29 Centers For Disease Control And Prevention Mosaic protein and restriction endonuclease assisted ligation method for making the same
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
JP2002524078A (ja) * 1998-09-04 2002-08-06 アヴェンティス パスツール リミテット゛ 子宮頸がんの治療
US20050100928A1 (en) * 1999-09-16 2005-05-12 Zycos Inc., A Delaware Corporation Nucleic acids encoding polyepitope polypeptides
US7026443B1 (en) * 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
ATE418997T1 (de) * 2000-07-06 2009-01-15 Univ Georgetown Stabile (fixierte) formen von viralen l1 capsidproteinen, deren fusionsproteinen, und deren verwendungen
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
CN101367869B (zh) 2000-09-30 2012-12-05 北京万泰生物药业股份有限公司 用于预防、诊断及治疗戊型肝炎病毒的多肽,及它们作为诊断试剂和疫苗
AUPR446801A0 (en) 2001-04-18 2001-05-17 University Of Queensland, The Novel compositions and uses therefor
AU2003215244A1 (en) * 2002-02-14 2003-09-04 Curagen Corporation Complexes and methods of using same
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
AU2002950183A0 (en) * 2002-07-12 2002-09-12 The Council Of The Queensland Institute Of Medical Research Expression of hydrophobic proteins
AU2003282731B2 (en) 2002-10-03 2009-01-08 Wyeth Holdings Corporation Human papillomavirus polypeptides and immunogenic compositions
GB0222953D0 (en) * 2002-10-03 2002-11-13 Glaxo Group Ltd Novel Compounds
JP2006503914A (ja) * 2002-10-21 2006-02-02 エムジーアイ ファーマ バイオロジックス インコーポレイテッド ヒトパピローマウイルス媒介性疾患を治療するための組成物および方法
WO2004098497A2 (en) * 2003-04-28 2004-11-18 Genencor International, Inc. Cd4+ human papillomavirus (hpv) epitopes
US20080160089A1 (en) * 2003-10-14 2008-07-03 Medivas, Llc Vaccine delivery compositions and methods of use
AU2005222776A1 (en) * 2003-12-31 2005-09-29 Genimmune N.V. Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
CA2590337C (en) 2004-12-15 2017-07-11 Neuralab Limited Humanized amyloid beta antibodies for use in improving cognition
EP1926780B1 (en) 2005-09-22 2013-08-14 Medivas, LLC Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
WO2007038246A2 (en) * 2005-09-22 2007-04-05 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
JP2009524584A (ja) * 2005-12-07 2009-07-02 メディバス エルエルシー ポリマー−生物製剤送達組成物を構築するための方法
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
WO2009017467A1 (en) 2007-07-27 2009-02-05 Elan Pharma International Limited Treatment of amyloidogenic diseases
CA2649672C (en) * 2006-05-02 2015-07-07 Medivas, Llc Delivery of ophthalmologic agents to the exterior or interior of the eye
KR100904844B1 (ko) * 2006-08-28 2009-06-25 성균관대학교산학협력단 인유두종 바이러스（ｈｐｖ）유전자를 포함하는자궁경부암의 치료 또는 예방용 ｄｎａ 백신
US8003097B2 (en) 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
EP2178944A1 (en) * 2007-07-24 2010-04-28 Medivas, LLC Biodegradable cationic polymer gene transfer compositions and methods of use
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
CN102186484A (zh) * 2008-08-13 2011-09-14 梅迪沃什有限公司 Aabb-聚(酯肽)可生物降解聚合物及其使用方法
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
CA2741762C (en) * 2008-10-31 2018-04-03 Trovagene, Inc. A genetic marker for detection of human papillomavirus
CA2653478A1 (en) * 2009-01-23 2010-07-23 Gregg Martin Automated wash system for industrial vehicles
US9050287B2 (en) * 2009-01-23 2015-06-09 The Trustees Of The University Of Pennsylvania Vaccines for human papilloma virus and methods for using the same
EP2723801B1 (en) 2011-06-23 2017-01-18 DSM IP Assets B.V. New biodegradable polyesteramide copolymers for drug delivery
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
WO2013055326A2 (en) * 2011-10-12 2013-04-18 The Trustees Of The University Of Pennsylvania Vaccines for human papilloma virus and methods for using the same
AU2014248535B2 (en) 2013-03-12 2017-03-30 Inovio Pharmaceuticals, Inc. Improved vaccines for human papilloma virus and methods for using the same
CN107106509B (zh) 2014-12-18 2021-11-30 帝斯曼知识产权资产管理有限公司 用于递送酸敏感药物的药物递送系统
SG11202008539YA (en) * 2018-03-06 2020-10-29 Precigen Inc Human papillomavirus vaccines and uses of the same
AU2021385551A1 (en) * 2020-11-25 2023-06-22 Precigen, Inc. Human papilloma virus vaccines and uses of the same for hpv associated diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2643817B1 (fr) * 1989-03-06 1993-12-17 Transgene Sa Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus
KR910016343A (ko) * 1990-03-20 1991-11-05 스타인, 부그 사람 파필로마바이러스(hpv) 16 단백질의 혈청반응성 에피토프
DE4015044A1 (de) * 1990-05-10 1991-11-14 Behringwerke Ag Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18
CN1067382A (zh) * 1990-09-26 1992-12-30 布里斯托尔-迈尔斯斯奎尔公司 人类乳头状瘤病毒肽的表达以及在致免疫组合物中的应用
DE69131992T2 (de) * 1990-12-12 2000-06-29 Csl Ltd., Parkville Papillomavirusuntereinheit-impfstoff
US5464936A (en) 1990-12-21 1995-11-07 Cetus Oncology Corporation Compositions for identification of papillomavirus replication inhibitors
GB9105383D0 (en) * 1991-03-14 1991-05-01 Immunology Ltd An immunotherapeutic for cervical cancer
GB9207701D0 (en) * 1992-04-08 1992-05-27 Cancer Res Campaign Tech Papillomavirus e7 protein
WO1994012629A1 (en) 1992-12-02 1994-06-09 Baylor College Of Medicine Episomal vectors for gene therapy
EP0769963A4 (en) * 1994-07-27 1999-07-28 Commw Scient Ind Res Org POLYEPITOPE VACCINES
DE4447664C2 (de) 1994-10-07 1999-04-15 Lutz Prof Dr Gissmann Fusionsproteine, Verfahren zu deren Herstellung sowie deren Anwendung
AUPN015794A0 (en) * 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
US5955087A (en) * 1995-02-24 1999-09-21 Cantab Pharmaceuticals Research Limited Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation

Also Published As

Publication number Publication date
CA2228221C (en) 2011-05-17
CA2228221A1 (en) 1997-02-13
JP2007054074A (ja) 2007-03-08
EP0840747A4 (en) 2002-10-23
EP1847549A3 (en) 2008-01-16
WO1997005164A1 (en) 1997-02-13
JPH11510688A (ja) 1999-09-21
ZA966381B (en) 1997-05-02
NZ313108A (en) 1999-05-28
US6726912B1 (en) 2004-04-27
US6365160B1 (en) 2002-04-02
EP1847549A2 (en) 2007-10-24
EP0840747A1 (en) 1998-05-13

Similar Documents

Publication Publication Date Title
AUPN443995A0 (en) Papillomavirus polyprotein
AU4878096A (en) Hepatitis b vaccine
AU6304996A (en) Vaccines against hepatitis c
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4382896A (en) Acetylimidazobenzodiazepines
EP0737905A3 (de) Thermostatventil
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU6840796A (en) Sack-holder
AU2161897A (en) Helicopter-airplane
AU6510296A (en) Papillomavirus polyprotein constructs
AU1205497A (en) Vaccine component
HK1009455A (zh) 乳头状瘤病毒
AU2609095A (en) Compartmentalizer
AU2012697A (en) Bottle-opener
AU4831396A (en) Pyrazolotetracyclines
AU4531096A (en) Foodpellet
AU6826896A (en) Vaccines
AU1844999A (en) Self-setting-spring-steel wire-fish-hook
AU1654495A (en) Dunnee-bar
HK1015271A (zh) 疫苗
HK1010212A (en) Vaccines against hepatitis c
AUPN580495A0 (en) Can
AU3066795A (en) Multi-trainer
AU3282795A (en) Sincromofonia